Data insights 6 March 2024 Deal analysis part three – the undecided Of the big oncology deals since 2016, there are still plenty that could go either way. Read more
Deals Trial results 22 October 2023 ESMO 2023 – Daiichi shows why Merck paid $1.5bn for CDH6 Read more